Table 1.
Characteristics of patients with peripheral artery disease.
| Characteristic (Units) | Measurement N = 503 |
|---|---|
| Age (years) | 70.77 ± 12.39 |
| Sex male | 326 (64.81) |
| female | 177 (35.19) |
| BMI (kg/m2) | 23.97 ± 3.91 |
| CHF (C) | 238 (47.32) |
| HTN | 403 (86.68) |
| DM | 376 (74.75) |
| Stroke/TIA | 91 (18.09) |
| Vascular disease | 503 (100) |
| HPL | 241 (47.91) |
| SMK | 195 (38.77) |
| CAD | 263 (52.29) |
| CABG | 53 (10.54) |
| PCI | 239 (47.51) |
| Old MI | 79 (15.71) |
| COPD | 21 (4.17) |
| CKD | 319 (63.42) |
| HD/PD | 181 (35.98) |
| Cr (mg/dL) | 3.26 ± 3.04 |
| Af | 120 (23.86) |
| Imd | 21 (4.03) |
| HbA1C (%) | 7.32 ± 1.86 |
| Cholesterol (mg/dL) | 149.65 ± 39.42 |
| LDL (mg/dL) | 83.37 ± 33.35 |
| HDL (mg/dL) | 42.94 ± 15.21 |
| TG (mg/dL) | 130.87 ± 83.79 |
| Glu (mg/dL) | 145.60 ± 69.49 |
| TG/HDL | 3.69 ± 3.86 |
| ASA | 385 (76.54) |
| Clopidgrel | 427 (84.89) |
| Cilostazol | 301 (59.84) |
| Pentoxyphilline | 19 (0.19) |
| Direct oral anticoagulant (DOAC) | 73 (14.51) |
| ACEIARB | 220 (43.74) |
| Statin | 283 (56.26) |
| Betablocker | 189 (37.57) |
| CCB | 201 (39.96) |
| Insulin | 106 (21.07) |
| Rutherford = 1 | 0 (0) |
| Rutherford = 2 | 0 (0) |
| Rutherford = 3 | 0 (0) |
| Rutherford = 4 | 130 (25.84) |
| Rutherford = 5 | 316 (62.82) |
| Rutherford = 6 | 57 (11.33) |
| Target vessel CIA | 41 (8.15) |
| Target vessel EIA | 45 (8.95) |
| Target vessel CFA | 27 (5.37) |
| Target vessel SFA | 285 (56.66) |
| Target vessel ATA | 248 (49.30) |
| Target vessel popliteal | 107 (21.27) |
| Target vessel peroneal artery | 96 (19.09) |
| Target vessel tibiofibular TP trunk | 64 (12.72) |
| Target vessel PTA | 196 (38.97) |
| Target vessel DPA | 15 (2.98) |
| Target vessel plantar artery | 23 (4.57) |
All measures are depicted as the mean ± standard deviation or n (%). BMI: body mass index; CHF: congestive heart failure; HTN: hypertension; DM: diabetes mellitus; TIA: transient ischemic attack; HPL: hyperlipidemia; SMK: smoking status; CAD: coronary artery disease; CABG: coronary artery bypass graft; PCI: percutaneous coronary intervention; MI: myocardial infarction; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease; HD/PD: hemodialysis/peritoneal dialysis; Cr: creatinine; Af: atrial fibrillation; Imd: immune-related disease; HbA1C: hemoglobin A1C; LDL: low-density lipoprotein; HDL: high-density lipoprotein; TG: triglyceride; Glu: glucose; ASA: acetylsalicylic acid; ACEIARB: angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB); CCB: calcium channel blocker; Rutherford: Rutherford classification; CIA: common iliac artery; EIA: external iliac artery; CFA: common femoral artery; SFA: superficial femoral artery; ATA: anterior tibial artery; tibiofibular TP trunk: tibiofibular tibioperoneal trunk; PTA: posterior tibial artery; DPA: dorsalis pedis artery.